TL;DR: Brand partners briefing us on cream and lotion development almost always focus on texture and actives — which is fair — but the variables that actually determine whether a batch passes or fails at 45°C, 12 weeks, are buried in the raw material CoA
TL;DR: When a new emollient lot arrives and the CoA looks clean, we run it through what we call our ML-04 incoming screen before it touches a batch
Looking at what’s already covered in this category, there’s a clear gap: none of those articles address raw material selection criteria and qualification thresholds from an incoming goods and formulation-risk perspective. The existing articles cover emulsifier selection, texture engineering, stability protocols, and regulatory labeling — but not the upstream decision of which materials to specify, what numbers to require, and how to screen out problem ingredients before they reach a batch.
This article will cover: purity thresholds, heavy metal limits, microbial specs, peroxide values for emollients, supplier CoA red flags, and how to build a decision matrix for material approval. That’s a genuinely uncovered angle.
Key Technical Parameters #
Every moisturizer failure we’ve traced back to its root cause started with a material specification gap, not a formulation error. Brand partners briefing us on cream and lotion development almost always focus on texture and actives — which is fair — but the variables that actually determine whether a batch passes or fails at 45°C, 12 weeks, are buried in the raw material CoA. This guide covers the four most consequential material selection criteria for cream and lotion formulations: oxidative stability of emollients, purity and heavy metal compliance, microbial baseline, and functional performance thresholds. It’s most relevant to brands developing new SKUs or switching suppliers mid-project, where material substitution risk tends to be underestimated.
What the CoA Doesn’t Show You — And Where to Look Instead #
When a new emollient lot arrives and the CoA looks clean, we run it through what we call our ML-04 incoming screen before it touches a batch. The CoA tells you acid value, color, and viscosity. What it doesn’t tell you is oxidative load at the time the material reaches our tank — and for polyunsaturated emollients like rosehip oil, squalane (shark-derived, not sugarcane), and linoleic-rich marula, that gap matters enormously.
Peroxide value is the number we care about most for lipid-rich emollients. Our intake threshold is ≤5 mEq/kg for high-unsaturation oils used in leave-on formulations. Above 10 mEq/kg, we’ve seen accelerated rancidity develop in emulsion by week 8 at 40°C, even when antioxidant systems are in place. Suppliers will ship material that passes their internal spec at ≤10 mEq/kg, which is the common industry ceiling — but for a 24-month product with a premium positioning, that buffer is too thin. We push back and require ≤5 mEq/kg with a retest date no older than 60 days from delivery.
Anisidine value is the other half of the oxidation picture, and far fewer brands specify it. Peroxide value measures primary oxidation products; anisidine value (AV) measures secondary aldehydes, which are the compounds actually responsible for off-odor. Our internal cutoff for leave-on creams is AV ≤3 for vegetable-derived emollients, and the total oxidation index (TOTOX = 2 × PV + AV) must stay ≤15. A material can technically show low peroxide and still carry high secondary oxidation load. We’ve had lots arrive from three separate brokers where PV was fine but TOTOX hit 18–22. Those go back.
For synthetic emollients — esters like isopropyl myristate, C12-15 alkyl benzoate, dicaprylyl carbonate — the oxidation risk is lower, but acid value becomes the gating parameter. Elevated acid value signals hydrolysis during storage, which affects emulsion pH and can interfere with pH-sensitive actives. Our limit: acid value ≤0.2 mg KOH/g for synthetic esters used in formulations targeting pH 5.0–6.0.
Heavy metal limits are where EU compliance intersects with material selection in a way that catches brands off guard. Under EU Cosmetics Regulation 1223/2009, impurity levels for heavy metals in finished products must not pose a risk to human health — the practical benchmark most labs use is ≤10 ppm lead, ≤5 ppm arsenic, ≤1 ppm mercury, ≤5 ppm cadmium. The problem is that mineral-derived ingredients — zinc oxide, titanium dioxide, kaolin, mica — carry variable heavy metal impurity profiles depending on mine source and refining process. We require ICP-MS heavy metal panels on every new mineral ingredient lot and on any lot from a supplier we haven’t audited. Without that, you’re relying on the supplier’s word, and that’s not a comfortable place to be when you’re filing in the EU.
Our barrier repair and ceramide cream formulations are particularly exposed here because they often combine multiple mineral and botanical inputs in the same base.
The Functional Performance Criteria That Actually Differentiate Materials #
Emollient selection is where brand briefs and formulation reality diverge most visibly. A brand asks for a “lightweight, non-greasy moisturizer with a velvet finish.” What that translates to in material terms is a polarity index in the mid-range, spreading coefficient above a certain threshold, and skin feel that panels can score consistently. Those are measurable. The problem is that supplier data sheets give you spreading coefficient at 25°C on glass — which correlates loosely, at best, to skin feel on living tissue.
In our lab, we use a two-stage screening: a trained panel rub-out test at 20 minutes post-application (scored 1–10 for greasiness, slip, and absorbency), followed by a Tewameter measurement at the 1-hour mark to confirm occlusion level. For a lightweight O/W day cream in the 30–50% emollient range, we expect greasiness score ≤3/10 and TEWL reduction of 15–25% at 1 hour versus untreated control. Materials that pass the supplier data sheet but fail both of those are more common than you’d expect.
Silicone-free briefs are becoming standard for EU clean beauty brands, and this is where the functional gap is hardest to fill. Cyclopentasiloxane and dimethicone are exceptionally good at delivering low greasiness scores — in our panel tests they consistently land at 1.5–2.5/10. Silicone-free alternatives that match that range are limited. Hydrogenated polyisobutene performs reasonably well (greasiness ~3.5/10 in our tests), and isododecane can push lower, but it has a volatility profile that affects formula aesthetics in a different way. We’re still not fully satisfied with any single silicone-free alternative for very dry-climate formulations. The performance data and the on-pack story don’t always point to the same ingredient.
One clinical data point worth referencing: a randomized, split-face, double-blind study (n=46, 8 weeks) comparing a ceramide-based barrier cream using high-purity phytosphingosine-rich ceramide 3 versus a synthetic ceramide 3 analog showed a 28% improvement in transepidermal water loss in the phytosphingosine group versus 19% in the synthetic group at week 8, measured by Tewameter TM300. The difference was meaningful — but the phytosphingosine fraction adds roughly 30–40% to the ceramide raw material cost, which is something most project briefs don’t account for upfront.
Rheology modifiers deserve their own selection criteria, but they’re often treated as interchangeable commodities. They’re not. Carbomer grades — Carbopol 980 versus 940 versus ETD 2020 — have meaningfully different salt tolerance and electrolyte sensitivity. In a formula with ≥0.5% niacinamide (which is essentially universal now), Carbopol 940 can show viscosity drop of 40–60% due to ionic disruption. ETD 2020 holds much better under those conditions. We log these failures under what we call our Category B incompatibility register, and carbomer-niacinamide collapse is one of the most common entries going back to 2020.
Decision Matrix: Selecting Emollients and Key Functional Materials #
The table below reflects how we evaluate candidate materials at the brief intake stage. It’s not exhaustive — different formulation types shift the weighting — but these are the parameters we check on every project.
| Material Category | Key Selection Parameter | Our Intake Threshold | Common Failure Mode |
|---|---|---|---|
| Vegetable / unsaturated oils | Peroxide value + TOTOX | PV ≤5 mEq/kg; TOTOX ≤15 | Rancidity by week 8 at 40°C |
| Synthetic esters (IPM, C12-15 AB) | Acid value | ≤0.2 mg KOH/g | pH drift in active formulas |
| Mineral powders (ZnO, TiO₂, kaolin) | Heavy metals (ICP-MS) | Pb ≤10 ppm, As ≤5 ppm, Hg ≤1 ppm | EU regulatory non-compliance |
| Carbomer / polyacrylate thickeners | Grade vs. electrolyte load | Match grade to ionic strength | 40–60% viscosity drop with niacinamide |
| Ceramides (natural vs. synthetic) | Purity, sphingoid base profile | ≥95% purity, confirmed base composition | Efficacy gap vs. clinical expectations |
| Emulsifiers (non-ionic) | HLB value + impurity profile | HLB ±0.3 of spec; peroxide ≤3 mEq/kg | Emulsion creaming within 4 weeks |
The mineral powder row is the one that causes the most regulatory pain in EU submissions. The SCCS Scientific Opinion on nano-TiO₂ and ZnO is also relevant here — particle size characterization (confirm non-nano unless the formula explicitly requires nano-grade) should be part of every mineral ingredient CoA review.
Emulsifier purity is an underspecified area. We require peroxide value ≤3 mEq/kg on PEG-based emulsifiers, because oxidized ethoxylates accelerate lipid oxidation in the emulsion phase and compromise fragrance stability. Suppliers don’t always test for this — you have to ask.
For moisturizer and cream formulations where the emollient phase exceeds 25% of formula weight, we also require a DSC (differential scanning calorimetry) profile on waxy emollients like hydrogenated castor oil and candelilla wax to confirm melting point within ±2°C of specification. Batch-to-batch variation here directly affects pour temperature and can cause inconsistent texture in the final product.
Prevention: What to Specify Upfront to Avoid Downstream Failures #
Most material-related failures are preventable at the PO stage. Once a material is in the batch, the options narrow fast.
For every new material introduction, the specification sheet the supplier provides must include: peroxide value with test date, acid value, heavy metals panel (ICP-MS for minerals), microbial count (TPC ≤100 CFU/g for rinse-off inputs, ≤10 CFU/g for leave-on inputs per PCPC Guidelines and aligned with EU Cosmetics Regulation 1223/2009 Annex I requirements), and a retest/expiry date on the CoA.
Specify retest intervals in the PO, not just shelf life. A 24-month shelf life on a vegetable oil is meaningless if the lot was tested 18 months ago and has been stored in a warehouse with no temperature control. Our standard PO language requires CoA retest within 90 days of delivery for unsaturated lipid materials, 180 days for synthetic materials.
Ask for a supplier’s incoming material qualification report, not just a CoA. A CoA is a self-declaration. An independent third-party lab report is the document worth having. For any new supplier relationship, FDA Cosmetics Guidelines also reference good manufacturing practice standards that include ingredient qualification requirements — worth aligning your supplier brief to that framework, especially if the US market is in scope.
One document to request before placing any new mineral ingredient PO: the supplier’s particle size distribution report confirming non-nano status (primary particle D90 ≥100 nm). This one piece of paper prevents a significant regulatory exposure in EU registration.
Formulation Notes for Brand Partners #
When you brief us on a new moisturizer or cream project, the first three questions we ask are: target market (EU, US, CN, or multi-region), intended consumer skin type, and whether there’s a clean beauty or silicone-free positioning commitment. Those three answers change the material shortlist immediately.
The most common brief mistake we see is specifying a hero active at a concentration the brand has seen in a competitor’s product, without knowing whether the material grade they need to hit that performance claim is within their cost target. Ceramides are the clearest example. A brand will request “ceramide complex” at 2%, not realizing that’s the total ceramide blend weight, not the sphingolipid-active fraction. The grade that delivers clinical efficacy at that label claim costs significantly more than the generic ceramide blend. We walk through this in the first brief call to avoid a resampling cycle.
Lab samples run 2–3 weeks from confirmed material approval. Accelerated stability starts immediately at 40°C/75% RH and 50°C, with reads at 4 and 8 weeks. We initiate 24-month real-time ICH stability concurrently, per ICH Stability Guidelines. For clean-beauty formulations requiring silicone-free substitution, add one to two weeks for emollient screening before sampling begins.
Frequently Asked Questions #
Can we substitute one vegetable oil for another mid-project to reduce cost?
A: It depends on where you are in the stability timeline. If you’re still in the first 4 weeks of accelerated testing, a substitution is manageable. After a confirmed 8-week accelerated pass, it means restarting the clock — and if the replacement oil has a peroxide value above our 5 mEq/kg threshold, it’s not a cost saving, it’s a stability risk we won’t take.
Do we need ICP-MS for every lot or just the first qualification?
A: First qualification is mandatory. After that, it depends on the supplier’s audit status and your own risk tolerance. For mineral ingredients in EU-registered products, we recommend re-testing every 6 months or on lot change, not just at initial qualification. The SCCS Scientific Opinion on nano-materials is part of why we hold this position — lot-to-lot variation in particle size from the same supplier does happen.
Our brief says “no parabens, no phenoxyethanol” — does that affect material selection?
A: Yes, directly. Preservative-free or alternative-preservative briefs raise the microbial baseline requirement on incoming raw materials to ≤10 CFU/g across all inputs, not just finished product testing. Materials that are acceptable under a conventional preservative system become disqualifying above that threshold. We’ve had botanical extracts from otherwise reputable suppliers fail at 400–800 CFU/g. At that point, the brief is functionally incompatible with the ingredient unless we reformulate around it.
What’s the minimum order quantity and typical timeline for a new moisturizer with custom material selection?
A: Pilot batches start at 50 kg for initial evaluation. Commercial MOQ is typically 300–500 kg depending on formula complexity and packaging format. From confirmed brief to lab sample is 2–3 weeks. Full qualification including 8-week accelerated stability and packaging compatibility runs 10–14 weeks before production sign-off.
We’re planning to use a supplier we found online — should we just send you their CoA?
A: A CoA is a starting point, not a qualification. What we actually need is the supplier’s third-party lab report covering the parameters in our ML-04 intake screen — peroxide value, acid value, heavy metals panel, and microbial count. If the supplier can’t provide independent third-party testing, that’s useful information in itself. We’ve onboarded supplier-provided CoAs that looked fine and still had the material fail our incoming screen. The CoA and the actual incoming test result don’t always agree.
Have a product concept in mind? Contact our formulation team to request a complimentary brief review.